GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Malaysian Genomics Resource Centre Bhd (XKLS:0155) » Definitions » Valuation Rank

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Valuation Rank


View and export this data going back to 2010. Start your Free Trial

What is Malaysian Genomics Resource Centre Bhd Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Malaysian Genomics Resource Centre Bhd Valuation Rank Related Terms

Thank you for viewing the detailed overview of Malaysian Genomics Resource Centre Bhd's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Malaysian Genomics Resource Centre Bhd Business Description

Traded in Other Exchanges
N/A
Address
Jalan Teknologi 3/6, 8F, Taman Sains Selangor 1, Kota Damansara (PJU5), Petaling Jaya, SGR, MYS, 47810
Malaysian Genomics Resource Centre Bhd is a Malaysia-based company. The company's principal activities include enabling personalized and precision medicine through genetics, genomics, immunotherapy, and biopharmaceutical services, as well as investment holding. It offers genome sequencing and analysis (GSA) services, and genetic screening services (GSS). GSA services involve the sequencing and analysis of the DNA of humans, animals, plants, and microbes for biological information. The company provides GSS services through its own range of genetic screening tests under the brand Dtect which screens human DNA for genetic markers related to diseases and health conditions. It is also engaged in Research, development, and distribution of biopharmaceutical products and services.